-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Meet the Blood Editors (for in-person participants)

Program: Blood Journals Studio
Monday, December 11, 2023: 3:00 PM-4:00 PM
Halls G-H - Blood Journals Studio (San Diego Convention Center)
Panelists:
Philippe Armand, MD, PhD, Dana-Farber Cancer Institute and Erica M. Wood, MD, Monash University
Disclosures:
Armand: Enterome: Consultancy; GenMab: Consultancy; Merck: Consultancy, Honoraria, Research Funding; Bristol Myers Squibb: Consultancy, Research Funding; ATB Therapeutics: Consultancy; ADC Therapeutics: Consultancy; Genentech/Roche: Consultancy, Research Funding; Foresight Diagnostics: Consultancy; Kite - a Gilead company: Research Funding; Adaptive Biotechnologies: Research Funding; IGM: Research Funding; AstraZeneca: Consultancy, Research Funding; MSD: Consultancy, Research Funding; Tessa Therapeutics: Consultancy; Regeneron: Consultancy; Xencor: Consultancy; Affimed Therapeutics: Research Funding.
This session provides attendees the opportunity to meet with the associate editors of Blood. Learn about recent changes to the journal as well as the submission and peer-review processes and policies. Seating is limited and available on a first-come, first-served basis.
See more of: Blood Journals Studio
<< Previous Session | Next Session >>